Surabhi Nanda

787 total citations
32 papers, 520 citations indexed

About

Surabhi Nanda is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Surabhi Nanda has authored 32 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Obstetrics and Gynecology, 12 papers in Pediatrics, Perinatology and Child Health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Surabhi Nanda's work include Pregnancy and preeclampsia studies (13 papers), Gestational Diabetes Research and Management (7 papers) and Birth, Development, and Health (6 papers). Surabhi Nanda is often cited by papers focused on Pregnancy and preeclampsia studies (13 papers), Gestational Diabetes Research and Management (7 papers) and Birth, Development, and Health (6 papers). Surabhi Nanda collaborates with scholars based in United Kingdom, United States and India. Surabhi Nanda's co-authors include K. H. Nicolaides, Ranjit Akolekar, Argyro Syngelaki, Catherine Nelson‐Piercy, Liona C. Poon, Andrew Shennan, Katy Kuhrt, Rita Sarquis, Tony DeFalco and Steven Russell and has published in prestigious journals such as Blood, Metabolism and Multiple Sclerosis Journal.

In The Last Decade

Surabhi Nanda

29 papers receiving 501 citations

Peers

Surabhi Nanda
Surabhi Nanda
Citations per year, relative to Surabhi Nanda Surabhi Nanda (= 1×) peers Karol Charkiewicz

Countries citing papers authored by Surabhi Nanda

Since Specialization
Citations

This map shows the geographic impact of Surabhi Nanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surabhi Nanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surabhi Nanda more than expected).

Fields of papers citing papers by Surabhi Nanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surabhi Nanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surabhi Nanda. The network helps show where Surabhi Nanda may publish in the future.

Co-authorship network of co-authors of Surabhi Nanda

This figure shows the co-authorship network connecting the top 25 collaborators of Surabhi Nanda. A scholar is included among the top collaborators of Surabhi Nanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surabhi Nanda. Surabhi Nanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nanda, Surabhi, Spyros Bakalis, Srividhya Sankaran, et al.. (2024). Perinatal and neurodevelopmental outcomes of fetal isolated ventriculomegaly: a systematic review and meta-analysis. Translational Pediatrics. 13(4). 555–574. 3 indexed citations
2.
Armstrong, Róisín, Dawn Black, Russell S. Miller, et al.. (2023). Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study. Blood. 142(Supplement 1). 1224–1224. 2 indexed citations
3.
Wiles, Kate, Azza Ismail, Surabhi Nanda, et al.. (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. Multiple Sclerosis Journal. 29(3). 395–406. 1 indexed citations
4.
Hutter, Jana, Maria Deprez, Kelly Payette, et al.. (2023). Assessment of normal pulmonary development using functional magnetic resonance imaging techniques. American Journal of Obstetrics & Gynecology MFM. 5(6). 100935–100935. 8 indexed citations
5.
Nanda, Surabhi, et al.. (2022). Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis. Frontiers in Endocrinology. 13. 945543–945543. 17 indexed citations
6.
Hutter, Jana, Mary Rutherford, À Milan, et al.. (2022). Assessment of the fetal lungs in utero. American Journal of Obstetrics & Gynecology MFM. 4(5). 100693–100693. 14 indexed citations
7.
Hutter, Jana, Jacqueline Matthew, Tong Zhang, et al.. (2021). Assessment of the fetal thymus gland: Comparing MRI-acquired thymus volumes with 2D ultrasound measurements. European Journal of Obstetrics & Gynecology and Reproductive Biology. 264. 1–7. 2 indexed citations
8.
Hutter, Jana, Laurence H. Jackson, Alison Ho, et al.. (2021). The use of functional placental magnetic resonance imaging for assessment of the placenta after prolonged preterm rupture of the membranes in vivo: A pilot study. Acta Obstetricia Et Gynecologica Scandinavica. 100(12). 2244–2252. 9 indexed citations
9.
Nanda, Surabhi, et al.. (2020). Antenatal management of multiple pregnancies within the UK: A survey of practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 254. 74–78. 8 indexed citations
10.
Kuhrt, Katy, et al.. (2020). Placental abruption in a twin pregnancy at 32 weeks’ gestation complicated by coronavirus disease 2019 without vertical transmission to the babies. American Journal of Obstetrics & Gynecology MFM. 2(3). 100135–100135. 37 indexed citations
11.
Nanda, Surabhi, et al.. (2013). Maternal serum retinol-binding protein-4 at 11–13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 62(6). 814–819. 33 indexed citations
12.
Nanda, Surabhi, Catherine Nelson‐Piercy, & Lucy Mackillop. (2012). Cardiac disease in pregnancy. Clinical Medicine. 12(6). 553–560. 15 indexed citations
13.
Nanda, Surabhi, et al.. (2011). Maternal Serum Adiponectin at 11–13 Weeks of Gestation in Preeclampsia. Fetal Diagnosis and Therapy. 29(3). 208–215. 19 indexed citations
14.
Nanda, Surabhi, et al.. (2011). Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies. Metabolism. 61(5). 699–705. 31 indexed citations
15.
Nanda, Surabhi, et al.. (2011). Maternal Serum Adiponectin at 11–13 Weeks of Gestation in Pregnancies Delivering Small for Gestation Neonates. Fetal Diagnosis and Therapy. 29(4). 274–279. 5 indexed citations
16.
Nanda, Surabhi, et al.. (2011). Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia. Prenatal Diagnosis. 31(5). 479–483. 35 indexed citations
17.
Nanda, Surabhi, V. P. Varshney, & Sanjay Mishra. (2010). Biochemical characterization of the mechanism of binding of a regulatory protein to the spermatozoa- specific protein phosphatase in Swiss Albino Rat. Journal of Applied Biosciences. 27. 1715–1726.
18.
Nanda, Surabhi, et al.. (2010). Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenatal Diagnosis. 31(2). 135–141. 195 indexed citations
19.
Sharma, Vibha, et al.. (2009). Oxidative stress and coxsackievirus infections as mediators of beta cell damage: a review.. Scientific Research and Essays. 4(2). 42–58. 14 indexed citations
20.
Nanda, Surabhi, et al.. (2009). <i>Sox100B</i>, a <i>Drosophila</i> Group E Sox-domain Gene, Is Required for Somatic Testis Differentiation. Sexual Development. 3(1). 26–37. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026